The Patent Finder

Isoindolinone and Indazole Compounds for the Degradation of Egfr

C4 Therapeutics, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application PCT/US2020/066211, filed Dec 18, 2020. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 11,673,902Isoindolinone and Indazole Compounds for the Degradation of Egfr
In force
 · Medium confidence
UsedRemaining
C4 Therapeutics, Inc.In forceMedium confidence
US 12,371,442Isoindolinone and Indazole Compounds for the Degradation of Egfr
In force
 · High confidence
C4 Therapeutics, Inc.In forceHigh confidence
US 12,486,290Isoindolinone and Indazole Compounds for the Degradation of Egfr
In force
 · High confidence
C4 Therapeutics, Inc.In forceHigh confidence
Application 19/363,434Isoindolinone and Indazole Compounds for the Degradation of Egfr
Pending
Not granted
C4 Therapeutics, Inc.PendingNot granted
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by C4 Therapeutics, Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited